SCHEMBL6859360

SCHEMBL6859360

N=C1NC(=O)/C(=C\c2ccc(-c3ncccn3)o2)N1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 10/20 0.43
▸ GSK3B P49841 10/20 0.43
▸ PIK3CG P48736 3/20 0.43
▸ PIK3CA P42336 2/20 0.43
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ALPL P05186 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MCL1 Q07820 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PRF1 P14222 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CDK2 P24941 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860968 0.80 GSK3A (0.44) GSK3AGSK3BPIK3CGPIK3CAMEN1
SCHEMBL1116168 0.72 CA2 (0.42) PIK3CGPIK3CAMEN1KMT2AL3MBTL1
SCHEMBL1116169 0.72 CA2 (0.42) PIK3CGPIK3CAMEN1KMT2AL3MBTL1
SCHEMBL6858664 0.72 GSK3A (0.74) GSK3AGSK3BMEN1KMT2AL3MBTL1
SCHEMBL6858213 0.71 GSK3B (0.39) GSK3AGSK3BPIK3CGPIK3CAMEN1
SCHEMBL1115920 0.69 CYP2E1 (0.54) PIK3CGPIK3CAMEN1KMT2AL3MBTL1
SCHEMBL621836 0.63 PIK3CG (0.78) GSK3AGSK3BPIK3CGPIK3CAMEN1
SCHEMBL621835 0.63 PIK3CG (0.78) GSK3AGSK3BPIK3CGPIK3CAMEN1
SCHEMBL3362480 0.61 GSK3A (0.77) GSK3AGSK3BMEN1KMT2AL3MBTL1
SCHEMBL12990390 0.61 GSK3A (0.77) GSK3AGSK3BMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback